GI
RVMD icon

GAMMA Investing’s Revolution Medicines RVMD Stock Holding History

GAMMA Investing’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Buy
2,100
+501
+31% +$73.2K 0.01% 785
2026
Q1 		$156K Buy
1,599
+260
+19% +$26.3K 0.01% 1297
2025
Q4 		$107K Buy
1,339
+502
+60% +$32.9K 0.01% 1532
2025
Q3 		$39.1K Buy
837
+260
+45% +$10.2K ﹤0.01% 2152
2025
Q2 		$21.2K Sell
577
-25
-4% -$960 ﹤0.01% 2426
2025
Q1 		$21.3K Buy
602
+11
+2% +$447 ﹤0.01% 2341
2024
Q4 		$25.9K Sell
591
-29
-5% -$1.46K ﹤0.01% 2129
2024
Q3 		$28.1K Buy
620
+222
+56% +$9.67K ﹤0.01% 1897
2024
Q2 		$15.4K Buy
398
+142
+55% +$5.31K ﹤0.01% 2025
2024
Q1 		$8.25K Buy
256
+59
+30% +$1.75K ﹤0.01% 2159
2023
Q4 		$5.47K Buy
+197
New +$4.73K ﹤0.01% 2200

Other funds holding RVMD

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
SCA
Sandy Cove Advisors Hingham, Massachusetts $400M AUM 27.68% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

GAMMA Investing's RVMD Position: Q2 2026 in Review

GAMMA Investing increased its Revolution Medicines (RVMD) stake by 31% in Q2 2026, buying an estimated $73.2K and bringing the position to 2,100 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #785.

GAMMA Investing first reported a position in RVMD in Q4 2023 and has held it in 11 quarters since. 90 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • GAMMA Investing held 2,100 shares of Revolution Medicines worth $393K as of Q2 2026.
  • GAMMA Investing bought 501 Revolution Medicines shares in Q2 2026, an estimated $73.2K.
  • Revolution Medicines made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #785 holding.
  • GAMMA Investing first reported a position in Revolution Medicines in Q4 2023 and has held it in 11 quarters since.
  • 90 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.